Citations

Mayo Clinic

Showing 10 of 108572 citations.

Mediodorsal nucleus and its multiple cognitive functions
Golden, Erin C., Graff‐Radford, Jonathan , Benarroch, Eduardo E. , Jones, David T.

Neurology | October 21, 2016 | Volume: 87 | Issue: 20 | Pages: 2161-2168

10.1212/wnl.0000000000003344 | PMID 27770073 Get It

Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database
Dai, Chen-Yang, Wang, Yu-Ning, Wang, Long , Xie, Dong , Mao, Rui , Chen, Chang , Li, Mu , Chen, Tao , Yang, Ping

Oncotarget | October 21, 2016 | Volume: 7 | Issue: 47 | Pages: 77152-77162

10.18632/oncotarget.12809 | PMID 27780931 Get It

Ultrasonic method to characterize shear wave propagation in micellar fluids
Amador, Carolina , Otilio, Bruno L., Kinnick, Randall R., Urban, Matthew W.

The Journal of the Acoustical Society of America | October 21, 2016 | Volume: 140 | Issue: 3 | Pages: 1719-1726

10.1121/1.4962531 | PMID 27914388 Get It

Viscoelastic micellar fluid characteristics have been measured with mechanically generated shear waves and showed good agreement to shear oscillatory methods. In this paper, shear waves in wormlike micellar fluids using ultrasound were successfully generated and detected. Micellar fluids of different concentrations (100, 200, 300, and 400 mM) were studied with ultrasound-based and conventional rheology methods. The measured micellar fluid complex modulus from oscillatory shear tests between 0.001 and 15.91 Hz was characterized with an extended Maxwell fluid model. The elastic and viscous parameters found using rheological testing were used to estimate shear wave phase velocity over a frequency range from 100 to 500 Hz, and compared to shear wave velocity measured with ultrasound-based methods with a mean absolute error 0.02 m/s. The shear wave frequency content was studied and an increase in shear wave center frequency was found as a function of micellar fluid concentration. Moreover, the bias found in the shear wave group velocity with respect to rheological measurement is attributed to the micellar fluid viscous component. Finally, the shear wave phase velocity evaluated at the center frequency agreed well with the rheological measurements.
Systemic mastocytosis in adults: 2017 update on diagnosis, risk stratification and management
Pardanani, Animesh

American Journal of Hematology | October 21, 2016 | Volume: 91 | Issue: 11 | Pages: 1146-1159

10.1002/ajh.24553 | PMID 27762455 Get It

Disease overview:Systemic mastocytosis (SM) results from a clonal proliferation of abnormal mast cells (MC) in one or more extra‐cutaneous organs.Diagnosis: The major criterion is presence of multifocal clusters of morphologically abnormal MC in the bone marrow. Minor diagnostic criteria include elevated serum tryptase level, abnormal MC expression of CD25 and/or CD2, and presence of KITD816V.Risk stratification: The 2008 World Health Organization (WHO) classification of SM has been shown to be prognostically relevant. Classification of SM patients into indolent (SM), aggressive SM (ASM), SM associated with a clonal non‐MC lineage disease (SM‐AHNMD) and mast cell leukemia (MCL) subgroups is a useful first step in establishing prognosis.Management: SM treatment is generally palliative. ISM patients have a normal life expectancy and receive symptom‐directed therapy; infrequently, cytoreductive therapy may be indicated for refractory symptoms. ASM patients have disease‐related organ dysfunction; interferon‐α (±corticosteroids) can control dermatological, hematological, gastrointestinal, skeletal and mediator‐release symptoms, but is hampered by poor tolerability. Similarly, cladribine has broad therapeutic activity, with particular utility when rapid MC debulking is indicated; the main toxicity is myelosuppression. Imatinib has a therapeutic role in the presence of an imatinib‐sensitive KIT mutation or in KITD816‐unmutated patients. Treatment of SM‐AHNMD is governed primarily by the non‐MC neoplasm; hydroxyurea has modest utility in this setting; there is a role for allogeneic stem cell transplantation in select cases.Investigational drugs: Recent data confirms midostaurin's significant anti‐MC activity in patients with advanced SM. Am. J. Hematol. 91:1147–1159, 2016. © 2016 Wiley Periodicals, Inc.
Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis
Brinjikji, Waleed , Wood, Christopher P. , Iyer, Vivek , Lanzino, Giuseppe

Journal of Neurosurgery | October 21, 2016 | Volume: 127 | Issue: 2 | Pages: 302-310

10.3171/2016.7.jns16847 | PMID 27767404 Get It

OBJECTIVEPatients with hereditary hemorrhagic telangiectasia (HHT) are known to suffer from high rates of cerebral arteriovenous malformations (AVMs). The authors performed a systematic review and meta-analysis of the literature examining prevalence rates, characteristics, and clinical presentation of cerebral AVMs in the HHT population.METHODSTo identify studies on AVM prevalence and characteristics in the HHT population, 4 databases (MEDLINE, EMBASE, Scopus and Web of Science) were searched by a reference librarian with over 30 years experience in systematic reviews and meta-analysis. The search period was January 1, 1990–March 2016. The following search terms were used: hereditary hemorrhagic telangiectasia, Osler-Weber-Rendu syndrome, AVM, brain AVM, arteriovenous malformation, arteriovenous fistula, prevalence, and epidemiology. The authors identified studies that examined the prevalence rates, characteristics, and clinical presentation of cerebral AVMs in patients with HHT. They assessed overall AVM prevalence rates as well as prevalence rates by age, sex, HHT type, and country/region. They also systematically reviewed the characteristics of AVMs, including rupture status, location, clinical presentation, angioarchitecture, and Spetzler-Martin grade. Data were analyzed using a random-effects meta-analysis model.RESULTSThirty-nine studies were included in this meta-analysis. Thirty studies examined brain AVM prevalence rates in various HHT patient populations, and 18 studies examined AVM clinical and angiographic characteristics (9 studies examined both prevalence rates and AVM characteristics). The prevalence of brain AVMs in HHT patients was 10.4% (95% CI 7.9%–13.0%) with no significant difference between males (8.5%, 95% CI 4.9%–12.0%) and females (11.0%, 95% CI 5.9%–16.1%). Patients with HHT Type 1 (HHT1) had a significantly higher brain AVM prevalence (13.4%, 95% CI 9.5%–17.4%) compared with those with HHT Type 2 (HHT2) (2.4%, 95% CI 1.0%–3.8%) (p < 0.0001). In 55.2% (95% CI 38.3%–72.1%) of cases, the AVMs were symptomatic. Spetzler-Martin grade was 2 or less in 86.9% (95% CI 67.5%–95.2%) of patients.CONCLUSIONSThe prevalence of brain AVMs in the HHT population is about 10%. HHT1 patients are significantly more likely to have brain AVMs than HHT2 patients. Most AVMs in the HHT population are symptomatic. The Spetzler-Martin grade for these lesions is 2 or less in nearly 90% of patients.
Epidemiology of Polymyalgia Rheumatica 2000–2014 and Examination of Incidence and Survival Trends Over 45 Years: A Population‐Based Study
Raheel, Shafay , Shbeeb, Izzat, Crowson, Cynthia S. , Matteson, Eric L.

Arthritis Care & Research | October 21, 2016 | Volume: 69 | Issue: 8 | Pages: 1282-1285

10.1002/acr.23132 | PMID 27768840 Get It

ObjectiveTo determine time trends in the incidence and survival of polymyalgia rheumatica (PMR) over a 15‐year period in Olmsted County, Minnesota, and to examine trends in incidence of PMR in the population by comparing this time period to a previous incidence cohort from the same population base.MethodsAll cases of incident PMR among Olmsted County, Minnesota residents in 2000–2014 were identified to extend the previous 1970–1999 cohort. Detailed review of all individual medical records was performed. Incidence rates were age‐ and sex‐adjusted to the US white 2010 population. Survival rates were compared with the expected rates in the population of Minnesota.ResultsThere were 377 incident cases of PMR during the 15‐year study period. Of these, 64% were female and the mean age at incidence was 74.1 years. The overall age‐ and sex‐adjusted annual incidence of PMR was 63.9 (95% confidence interval [95% CI] 57.4–70.4) per 100,000 population ages ≥50 years. Incidence rates increased with age in both sexes, but incidence fell after age 80 years. There was a slight increase in incidence of PMR in the recent time period compared to 1970–1999 (P = 0.063). Mortality among individuals with PMR was not significantly worse than that expected in the general population (standardized mortality ratio 0.70 [95% CI 0.57–0.85]).ConclusionThe incidence of PMR has increased slightly in the past 15 years compared to previous decades. Survivorship in patients with PMR is not worse than in the general population.
Transapical versus transfemoral approach and risk of acute kidney injury following transcatheter aortic valve replacement: a propensity-adjusted analysis
Cheungpasitporn, Wisit , Srivali, Narat , Harrison, Andrew M. , Kittanamongkolchai, Wonngarm , Greason, Kevin L. , Thongprayoon, Charat , Kashani, Kianoush , Harrison, Andrew Marc , Cheungpasitporn, Wisit , Srivali, Narat

Renal Failure | October 21, 2016 | Volume: 39 | Issue: 1 | Pages: 13-18

10.1080/0886022x.2016.1244072 | PMID 27767371 Get It

Association of Kidney Function Biomarkers with Brain MRI Findings: The BRINK Study
Vemuri, Prashanthi , Jack, Clifford R. , Lundt, Emily S. , Weigand, Stephen D. , Zuk, Samantha M., Thostenson, Kaely, Kantarci, Kejal , Slinin, Yelena, Lakshminarayan, Kamakshi , Davey, Cynthia , Murray, Anne M. , Thostenson, Kaely B, Knopman, David S. , Reid, Robert I. , Slinin, Yelena , Jack, Clifford R , Vemuri, Prashanthi , Kantarci, Kejal , Lundt, Emily S

Journal of Alzheimer's Disease | October 21, 2016 | Volume: 55 | Issue: 3 | Pages: 1069-1082

10.3233/jad-160834 | PMID 27767995 Get It

USE OF FIBEROPTIC-GUIDED CO2 LASER IN THE TREATMENT OF UVEAL EFFUSION
Bausili, Maria Montserrat, Raja, Harish, Kotowski, Jacek, Nadal, Jeroni, Salomão, Diva R. , Keenum, Deborah G., Pulido, José S. , Bausili, Maria M

RETINAL Cases & Brief Reports | October 21, 2016 | Volume: 11 | Issue: 3 | Pages: 191-194

10.1097/icb.0000000000000357 | PMID 27768636 Get It

Background/Purpose: To report a new technique for treating patients with uveal effusion syndrome by the fiberoptic-guided CO2 laser. Methods: Interventional case report. A 74-year-old man presented with exudative detachment of the choroid secondary to uveal effusion syndrome. Partial-thickness sclerotomy and full-thickness sclerotomy were performed to treat the disease using a fiberoptic-guided CO2 laser. Results: After the surgery, the patient's visual acuity improved and choroidal folds disappeared. Conclusion: This technique allows concomitant coagulation and cutting, thereby reducing the risk of bleeding and providing better depth control.
In Reply to “Texting Rhythm With Temporal Predominance”
Tatum, William O. , Yelvington, Kirsten , Rodin, Ernst A.

Journal of Clinical Neurophysiology | October 21, 2016 | Volume: 33 | Issue: 6 | Pages: 570-571

10.1097/wnp.0000000000000354 | PMID 27768616 Get It